NewsRx Logo Login/Signup
Home Newsletters Products Library About Us Contact -- Search NewsRx

NewsRx | Free Trials
Advertisement
VerticalNews | Global Warming
Advertisement
NewsRx | Free Trials
Advertisement
----------
------------
NewsRx on Facebook
-----
Press Release Submissions
PR Login
*
*

cancer weekly

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of cancer weekly

Learn More

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now



Cancer Gene Therapy



Researchers from Sichuan University, Department of Gastroenterology describe findings in cancer gene therapy



December 18th, 2007

Research findings, 'Preoperative growth inhibition of human gastric adenocarcinoma treated with a combination of celecoxib and octreotide,' are discussed in a new report. In this recent study, researchers in Chengdu, People's Republic of China conducted a study "To gain insight into the histopathological responses and molecular targets in the inhibition of growth of human gastric cancer treated with celecoxib (a cyclooxygenase [COX]-2 inhibitor) combined with octreotide. Seventy five patients with gastric cancer undergoing curative gastrectomy or extended resection were randomly divided into 3 groups."

"The apoptosis of tumor cells was measured by terminal...


Source: cancer weekly (2007-12-18)

NewsRx Passes
Advertisement
More Articles

Related Topics

------------------------
Security by Verisign PR Login